Assembly Biosciences Stock Today
| ASMB Stock | USD 13.33 0.41 3.17% |
Performance10 of 100
| Odds Of DistressLess than 9
|
Assembly Biosciences is trading at 13.33 as of the 19th of April 2024, a 3.17 percent up since the beginning of the trading day. The stock's open price was 12.92. Assembly Biosciences has less than a 9 % chance of experiencing financial distress in the next few years and had a ok performance during the last 90 days. Equity ratings for Assembly Biosciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 17th of December 2010 | Category Healthcare | Classification Health Care |
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus infection in the United States. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California. The company has 5.48 M outstanding shares of which 42.59 K shares are presently shorted by private and institutional investors with about 2.2 trading days to cover. More on Assembly Biosciences
Moving against Assembly Stock
| 0.6 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
| 0.59 | PFE | Pfizer Inc Sell-off Trend | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 2nd of May 2024
Assembly Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Assembly Biosciences' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Assembly Biosciences or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President CEO, Director | John McHutchison | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation Analysts covering Assembly Biosciences report their recommendations after researching Assembly Biosciences' financial statements, talking to executives and customers, or listening in on Assembly Biosciences' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Assembly Biosciences. The Assembly consensus assessment is calculated by taking the average forecast from all of the analysts covering Assembly Biosciences. | |||||
Assembly Biosciences' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Assembly Biosciences' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Assembly Biosciences' financial leverage. It provides some insight into what part of Assembly Biosciences' total assets is financed by creditors.
| |||||
Assembly Biosciences (ASMB) is traded on NASDAQ Exchange in USA. It is located in 331 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 and employs 65 people. Assembly Biosciences is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 73.09 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Assembly Biosciences's market, we take the total number of its shares issued and multiply it by Assembly Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Assembly Biosciences conducts business under Biotechnology sector and is part of Health Care industry. The entity has 5.48 M outstanding shares of which 42.59 K shares are presently shorted by private and institutional investors with about 2.2 trading days to cover.
Assembly Biosciences currently holds about 116.69 M in cash with 22.74 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.41.
Check Assembly Biosciences Probability Of Bankruptcy
Ownership AllocationAssembly Biosciences retains a total of 5.48 Million outstanding shares. Assembly Biosciences retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Assembly Ownership Details
Assembly Stock Price Odds Analysis
What are Assembly Biosciences' target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Assembly Biosciences jumping above the current price in 90 days from now is about 24.36%. The Assembly Biosciences probability density function shows the probability of Assembly Biosciences stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.3205. This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Assembly Biosciences will likely underperform. Additionally, assembly Biosciences has an alpha of 0.4793, implying that it can generate a 0.48 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Assembly Biosciences to move above the current price in 90 days from now is about 24.36 (This Assembly Biosciences probability density function shows the probability of Assembly Stock to fall within a particular range of prices over 90 days) .
Assembly Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Assembly Biosciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Assembly Biosciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Assembly Biosciences' value.| Instituion | Recorded On | Shares | |
| Acadian Asset Management Llc | 2023-09-30 | 83.5 K | |
| Franklin Resources Inc | 2023-12-31 | 65.4 K | |
| Morgan Stanley - Brokerage Accounts | 2023-09-30 | 44.7 K | |
| Barclays Plc | 2023-09-30 | 35.9 K | |
| Charles Schwab Investment Management Inc | 2023-12-31 | 32.5 K | |
| Hrt Financial Llc | 2023-12-31 | 30.5 K | |
| Xtx Topco Ltd | 2023-09-30 | 25.2 K | |
| Ubs Group Ag | 2023-12-31 | 24.2 K | |
| Commonwealth Equity Services Inc | 17.9 K | ||
| Vanguard Group Inc | 2023-09-30 | 2.2 M | |
| Millennium Management Llc | 2023-09-30 | 1.4 M |
Assembly Biosciences Historical Income Statement
Assembly Biosciences Income Statement is one of the three primary financial statements used for reporting Assembly's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Assembly Biosciences revenue and expense. Assembly Biosciences Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Assembly Biosciences' Income Tax Expense is projected to decrease significantly based on the last few years of reporting. The current year's Total Other Income Expense Net is expected to grow to about 3.6 M, whereas Depreciation And Amortization is forecasted to decline to about 427.5 K. View More FundamentalsAssembly Stock Against Markets
Picking the right benchmark for Assembly Biosciences stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Assembly Biosciences stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Assembly Biosciences is critical whether you are bullish or bearish towards Assembly Biosciences at a given time. Please also check how Assembly Biosciences' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Assembly Biosciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Investing Opportunities Now
Investing OpportunitiesBuild portfolios using our predefined set of ideas and optimize them against your investing preferences |
| All Next | Launch Module |
Assembly Biosciences Corporate Directors
Assembly Biosciences corporate directors refer to members of an Assembly Biosciences board of directors. The board of directors generally takes responsibility for the Assembly Biosciences' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Assembly Biosciences' board members must vote for the resolution. The Assembly Biosciences board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Helen Kim | Independent Director | Profile | |
| Myron Holubiak | Independent Director | Profile | |
| Anthony Altig | Independent Director | Profile | |
| Susan Mahony | Director | Profile |
How to buy Assembly Stock?
Before investing in Assembly Biosciences, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Assembly Biosciences. To buy Assembly Biosciences stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Assembly Biosciences. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Assembly Biosciences stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Assembly Biosciences stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Assembly Biosciences stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Assembly Biosciences, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Assembly Stock please use our How to Invest in Assembly Biosciences guide.
Already Invested in Assembly Biosciences?
The danger of trading Assembly Biosciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Assembly Biosciences is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Assembly Biosciences. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Assembly Biosciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Assembly Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Assembly Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Assembly Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Assembly Biosciences Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Assembly Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For information on how to trade Assembly Stock refer to our How to Trade Assembly Stock guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for Assembly Stock analysis
When running Assembly Biosciences' price analysis, check to measure Assembly Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assembly Biosciences is operating at the current time. Most of Assembly Biosciences' value examination focuses on studying past and present price action to predict the probability of Assembly Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assembly Biosciences' price. Additionally, you may evaluate how the addition of Assembly Biosciences to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
Is Assembly Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Assembly Biosciences. If investors know Assembly will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Assembly Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (13.38) | Revenue Per Share 1.565 | Quarterly Revenue Growth (1.00) | Return On Assets (0.34) | Return On Equity (0.99) |
The market value of Assembly Biosciences is measured differently than its book value, which is the value of Assembly that is recorded on the company's balance sheet. Investors also form their own opinion of Assembly Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Assembly Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Assembly Biosciences' market value can be influenced by many factors that don't directly affect Assembly Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Assembly Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Assembly Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Assembly Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.